The stock of Stevanato Group Spa (STVN) has seen a -3.22% decrease in the past week, with a -6.63% drop in the past month, and a 8.74% flourish in the past quarter. The volatility ratio for the week is 6.43%, and the volatility levels for the past 30 days are at 5.50% for STVN. The simple moving average for the past 20 days is 0.19% for STVN’s stock, with a -18.24% simple moving average for the past 200 days.
Is It Worth Investing in Stevanato Group Spa (NYSE: STVN) Right Now?
Stevanato Group Spa (NYSE: STVN) has a price-to-earnings ratio of 40.55x that is above its average ratio. Additionally, the 36-month beta value for STVN is 0.57. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 4 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for STVN is 49.48M and currently, short sellers hold a 7.43% ratio of that float. The average trading volume of STVN on October 03, 2024 was 535.46K shares.
STVN) stock’s latest price update
Stevanato Group Spa (NYSE: STVN) has experienced a rise in its stock price by 0.75 compared to its previous closing price of 20.00. However, the company has seen a fall of -3.22% in its stock price over the last five trading days. businesswire.com reported 2024-10-01 that PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology and life sciences industries, announced today the expansion of its Vertiva® platform, which will include a 10mL option to be presented at CPHI Milan in October. The Vertiva® easy-to-use platform can be pre-programmed to accommodate different motor driven dosing profiles, from micro-precision basal delivery to full-c.
Analysts’ Opinion of STVN
Jefferies, on the other hand, stated in their research note that they expect to see STVN reach a price target of $29, previously predicting the price at $39. The rating they have provided for STVN stocks is “Hold” according to the report published on November 01st, 2023.
Stephens gave a rating of “Overweight” to STVN, setting the target price at $33 in the report published on September 26th of the previous year.
STVN Trading at 0.29% from the 50-Day Moving Average
After a stumble in the market that brought STVN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.34% of loss for the given period.
Volatility was left at 5.50%, however, over the last 30 days, the volatility rate increased by 6.43%, as shares sank -5.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.49% lower at present.
During the last 5 trading sessions, STVN fell by -3.36%, which changed the moving average for the period of 200-days by -28.93% in comparison to the 20-day moving average, which settled at $20.05. In addition, Stevanato Group Spa saw -26.16% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for STVN
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.28 for the gross margin
The net margin for Stevanato Group Spa stands at 0.11. The total capital return value is set at 0.1. Equity return is now at value 10.31, with 6.12 for asset returns.
Based on Stevanato Group Spa (STVN), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at 0.45. The debt to equity ratio resting at 0.23. The interest coverage ratio of the stock is 17.12.
Currently, EBITDA for the company is 263.27 million with net debt to EBITDA at 1.05. When we switch over and look at the enterprise to sales, we see a ratio of 4.85. The receivables turnover for the company is 2.22for trailing twelve months and the total asset turnover is 0.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.74.
Conclusion
In conclusion, Stevanato Group Spa (STVN) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
